(Q33901317)
Statements
Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B (English)
W Wiszniewski
M C Fondaneche
N Lambert
K Masternak
C Picard
L Notarangelo
K Schwartz
W Reith
C Alcaide
A Fischer
B Lisowska-Grospierre